From October 2023, the US Food and Drug Administration (FDA) will reject any new medical device with cybersecurity vulnerabilities. Under new rules, applicants must provide assurance of regular security updates and patches, a software bill of materials (SBOM), and a plan to monitor, identify and address cybersecurity issues, even after FDA approval. This legislation applies to medical devices that connect to the internet, use software, and have technology that could be vulnerable to a cybersecurity threat.
North Korean hackers step up phishing attacks on Ukraine government
North Korean state-sponsored cyber actor, TA406, is carrying out phishing attacks and credential-stealing operations against Ukrainian government entities to gather intelligence on the Russian invasion,
